AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) sold $15K-$50K of Bristol-Myers Squibb Company (BMY) stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Mar 2, 2017.
The trade happened on Feb 28, 2017, 2 days before it was made public.
BMY has moved +7.8% since the trade date, from $56.71 to $61.15 (Oct 2, 2026 close).
- Traded
- Feb 28, 2017
- Disclosed
- Mar 2, 2017
- Filing delay
- 2 days
- Price since
- +7.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (5)
More BMY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.